QUEST DIAGNOSTICS INC (DGX) Stock Price & Overview
NYSE:DGX • US74834L1008
The current stock price of DGX is 200.85 USD. Today DGX is down by -1.53%. In the past month the price increased by 7.79%. In the past year, price increased by 16.19%.
DGX Key Statistics
- Market Cap
- 22.343B
- P/E
- 20.39
- Fwd P/E
- 19.11
- EPS (TTM)
- 9.85
- Dividend Yield
- 1.63%
DGX Stock Performance
DGX Stock Chart
DGX Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to DGX. When comparing the yearly performance of all stocks, DGX is one of the better performing stocks in the market, outperforming 74.15% of all stocks.
DGX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DGX. DGX has an excellent profitability rating, but there are some minor concerns on its financial health.
DGX Earnings
On February 10, 2026 DGX reported an EPS of 2.42 and a revenue of 2.81B. The company beat EPS expectations (1.51% surprise) and beat revenue expectations (0.9% surprise).
DGX Forecast & Estimates
24 analysts have analysed DGX and the average price target is 220.47 USD. This implies a price increase of 9.77% is expected in the next year compared to the current price of 200.85.
For the next year, analysts expect an EPS growth of 6.73% and a revenue growth 6.52% for DGX
DGX Groups
Sector & Classification
DGX Financial Highlights
Over the last trailing twelve months DGX reported a non-GAAP Earnings per Share(EPS) of 9.85. The EPS increased by 9.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.95% | ||
| ROA | 6.09% | ||
| ROE | 13.78% | ||
| Debt/Equity | 0.72 |
DGX Ownership
DGX Latest News, Press Relases and Analysis
DGX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.63 | 99.891B | ||
| CI | THE CIGNA GROUP | 8.79 | 74.103B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 101.25 | 27.175B | ||
| LH | LABCORP HOLDINGS INC | 14.95 | 22.874B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.928B | ||
| DVA | DAVITA INC | 11.21 | 10.278B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.31 | 8.084B | ||
| CHE | CHEMED CORP | 16.96 | 5.675B | ||
| RDNT | RADNET INC | 80.91 | 5.16B | ||
| OPCH | OPTION CARE HEALTH INC | 15.46 | 4.765B | ||
| HIMS | HIMS & HERS HEALTH INC | 28.42 | 3.62B | ||
| HNGE | HINGE HEALTH INC-A | 28.76 | 3.609B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DGX
Company Profile
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 57,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Company Info
QUEST DIAGNOSTICS INC
500 Plaza Drive
Secaucus NEW JERSEY 07094 US
CEO: Stephen H. Rusckowski
Employees: 50500
Phone: 13026587581
QUEST DIAGNOSTICS INC / DGX FAQ
Can you describe the business of QUEST DIAGNOSTICS INC?
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 57,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Can you provide the latest stock price for QUEST DIAGNOSTICS INC?
The current stock price of DGX is 200.85 USD. The price decreased by -1.53% in the last trading session.
What is the dividend status of QUEST DIAGNOSTICS INC?
QUEST DIAGNOSTICS INC (DGX) has a dividend yield of 1.63%. The yearly dividend amount is currently 3.19.
What is the ChartMill rating of QUEST DIAGNOSTICS INC stock?
DGX has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of DGX stock?
QUEST DIAGNOSTICS INC (DGX) operates in the Health Care sector and the Health Care Providers & Services industry.
Is QUEST DIAGNOSTICS INC (DGX) expected to grow?
The Revenue of QUEST DIAGNOSTICS INC (DGX) is expected to grow by 6.52% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of DGX stock?
QUEST DIAGNOSTICS INC (DGX) has a market capitalization of 22.34B USD. This makes DGX a Large Cap stock.